STATCenter·
STAT+: The mystery of Moderna’s magic algorithm
A personalized cancer vaccine developed by Moderna and Merck may be a triumph of immunology and cancer biology. It might also be the triumph of an algorithm.
Read at STAT →
A personalized cancer vaccine developed by Moderna and Merck may be a triumph of immunology and cancer biology. It might also be the triumph of an algorithm.

<iframe src="https://statesidedaily.com/embed/cluster/af7d517f86acd15646b32d3a6fc585225bef095d" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: The mystery of Moderna’s magic algorithm"></iframe>